MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models

The transcription factor CEBPA is a master regulator of liver homeostasis, myeloid cell differentiation and is downregulated in several oncogenic diseases. MTL-CEBPA is a small activating RNA drug which upregulates gene expression of CEBPA for treatment of hepatocellular carcinoma (HCC). We investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kai-Wen, Tan, Choon Ping, Reebye, Vikash, Chee, Cheng Ean, Zacharoulis, Dimitris, Habib, Robert, Blakey, David C., Rossi, John J., Habib, Nagy, Sodergren, Mikael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431011/
https://www.ncbi.nlm.nih.gov/pubmed/34502076
http://dx.doi.org/10.3390/ijms22179168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431011/
https://www.ncbi.nlm.nih.gov/pubmed/34502076
http://dx.doi.org/10.3390/ijms22179168

Ejemplares similares